Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Microsoft Signs Patent Agreement With Amdocs

RELATED NEWS
Trade MSFT now with 
7/24/2012 12:26 PM ET

Microsoft Corp. (MSFT: Quote) Tuesday said it has signed a patent cross-license agreement with Amdocs Software Systems Ltd., thereby providing mutual access to each company's patent portfolio.

The agreement will also allow Amdocs to use Linux-based servers in Microsoft's data centers.

The agreement adds to more than a 1,100 patent agreements signed by Microsoft in the past decade.

Click here to receive FREE breaking news email alerts for Microsoft Corporation and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks have shown a notable move to the downside in early trading on Friday amid lingering concerns about the outlook for the Federal Reserve's asset purchase program. The major averages have slid firmly into negative territory, adding to the modest losses posted in the previous session. The major averages are currently posting notable losses, near their lows for the young session. After reporting a sharp drop in new orders for manufactured durable goods in the previous month, the Commerce Department released a report on Friday showing that durable goods orders rebounded by more than anticipated in the month of April. The report said durable goods orders surged up by 3.3 percent in April after tumbling by a revised 5.9 percent in March. The popular e-mail management app Mailbox, developed by Orchestra Inc., has been updated to be compatible with Apple's iPad. Orchestra disclosed the news of the update through its official blog. "You asked, we listened. Mailbox is now available for iPad, so you can swipe your way to inbox zero on all your iOS devices," Orchestra's brief blog read.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.